Programme

Overview: This pitch session explores the next frontiers of medical physics research in 5 key areas of radiotherapy. Speakers will present future research directions on: - new treatment units’ development, - dose calculation and optimization as dynamic, biology-driven tasks expanded to incorporate emerging synergies like theranostics or dose-to-blood calculation. - response modelling to shift from dose-based toward response-guided therapy including spatial, temporal and biological information, - new detector developments and dosimetry audits - optimizing the use and integration of imaging data in effective longitudinal models and decision making. This session will inspire the audience to develop bold new research ideas for multi-modality approaches that can transform the radiotherapy landscape.

Overview: Soft tissue sarcomas are one of the most challenging topics in radiation oncology from both a technical and oncological standpoint, due to their histological heterogeneity, complex anatomy, and limited prospective evidence. This session explores the clinical and technological frontiers of sarcoma radiotherapy in different settings: from the current standard of care and emerging trial data for retroperitoneal sarcomas, to definitive high-dose strategies (including IMRT, hypofractionation, spatially fractionated techniques, and particle therapy) for unresectable disease; SBRT in the oligometastatic setting; and the evolving role of daily adaptive radiotherapy in optimising target coverage and sparing organs at risk